Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu - Fierce Pharma
Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu Fierce Pharma
Pfizer, Arvinas win $85M upfront in Rigel licensing pact for new breast cancer med Veppanu Fierce Pharma
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.